It’s easy to incorporate LEXETTE Foam into your life when you need to. But before you begin, there are a few things you should know.
It’s recommended that you apply a thin layer of LEXETTE Foam to the affected areas 2 times each day for up to 2 weeks. Do not use more than 50 grams (one can) of LEXETTE Foam in one week. Also be sure to use LEXETTE Foam exactly as your doctor tells you.*
step 1
Before applying LEXETTE Foam for the first time, remove cap and break the small tab at the base of the actuator by gently pushing the actuator away from the tab as shown. Do not break the hinge on the actuator.
step 2
Shake the can well before use.
step 3
Turn the can completely upside down.
step 4
Press down on the actuator to dispense a small amount of the foam into the palm of your hand.
step 5
Apply a thin layer of LEXETTE Foam to the affected skin area and gently rub until the foam disappears. Repeat steps 4 and 5 to all the affected areas as prescribed by your healthcare provider.
step 6
After applying LEXETTE Foam, put the cap back on the can.
step 7
Wash your hands after applying LEXETTE Foam
unless you are using the medicine to treat your hands.
LEXETTE Foam is for skin use only. Do not get LEXETTE Foam in your mouth, eyes, or vagina.
Lexette® Foam (halobetasol propionate) is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older.
Important Safety Information
Lexette® Foam (halobetasol propionate) is a topical corticosteroid that has been shown to suppress the hypothalamic-pituitary-adrenal (HPA) axis.
Systemic effects of topical corticosteroids may include reversible HPA axis suppression, with the potential for glucocorticosteroid insufficiency. This may occur during treatment or upon withdrawal of treatment of the topical corticosteroid.
The potential for hypothalamic-pituitary adrenal (HPA) suppression with LEXETTE Foam was evaluated in a study of 25 adult subjects with moderate to severe plaque psoriasis involving ≥15% of their body surface area. LEXETTE Foam produced laboratory evidence of HPA axis suppression when used twice daily for two weeks in 6 out of 25 (24%) adult subjects with plaque psoriasis. Recovery of HPA axis function was generally prompt with the discontinuation of treatment.
Systemic effects of topical corticosteroids may also include Cushing's syndrome, hyperglycemia, and glucosuria. Use of more than one corticosteroid-containing product at the same time may increase the total systemic exposure to topical corticosteroids.
Local adverse reactions from topical corticosteroids may include atrophy, striae, telangiectasias, burning, itching, irritation, dryness, folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, and miliaria. These may be more likely to occur with occlusive use, prolonged use, or use of higher potency corticosteroids, including LEXETTE Foam.
Some local adverse reactions may be irreversible. Use of topical corticosteroids may increase the risk of posterior subcapsular cataracts and glaucoma.
Medical Information & Adverse Drug Events Reporting
To report a suspected adverse reaction from one of our products, please contact Mayne Pharma at 1-844-825-8500 or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
